Related Experiment Video
Updated: Jul 3, 2026
10:19
Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
Published on: August 9, 2012
19.4K
Editorial: Special Issue "Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)"
Jochen Neuhaus1, Andreas Gonsior2, Mandy Berndt-Paetz1
1Research Laboratory, Department of Urology, University of Leipzig, 04103 Leipzig, Germany.
Diagnostics (Basel, Switzerland)
|July 27, 2022
Summary
Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a chronic bladder condition causing pain. Research is ongoing to understand its complex causes and find effective treatments for this debilitating disease.
Area of Science:
- Urology
- Pain Medicine
- Chronic Disease Research
Background:
- Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a chronic condition characterized by bladder pain and urinary urgency.
- The exact etiology and complex pathophysiology of IC/BPS remain largely unknown.
- This condition significantly impacts patients' quality of life.
Discussion:
- Understanding the multifaceted nature of IC/BPS is crucial for developing targeted therapies.
- Current research explores various contributing factors, including inflammation, nerve dysfunction, and urothelial abnormalities.
- The diagnostic challenges and treatment complexities of IC/BPS necessitate further investigation.
Key Insights:
- IC/BPS presents a significant clinical challenge due to its unknown origins.
- The complex pathophysiology requires a multidisciplinary approach to unravel its mechanisms.
- Identifying reliable biomarkers and therapeutic targets is a key research priority.
Outlook:
- Future research aims to elucidate the precise molecular and cellular mechanisms underlying IC/BPS.
- Advancements in diagnostic tools and treatment strategies are anticipated.
- A deeper understanding will pave the way for improved patient outcomes and management of IC/BPS.
More Related Videos
Related Concept Videos
01:17Irritable Bowel Syndrome I: Introduction
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:23Irritable Bowel Syndrome
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...